Evotec Stock: Confidence Wanes
Evotec’s share price has fallen sharply over the past year, now hovering just above its lowest point in 52 weeks. The stock closed at around €5.24, marking a 37% drop from its peak and raising concerns about further declines.
The company’s struggles deepened in the third quarter of 2025, with a reported loss per share of €0.24 and shrinking revenue. These weak financial results have added pressure to an already difficult situation.
A key factor in the recent slump was the exit of Novo Holdings, a long-time major shareholder. In December 2025, the firm sold off 9.4 million shares, reducing its stake by 5.3%. This move left investors uneasy, as no new strategic backers have stepped in to fill the gap. Currently, Triton holds roughly 10% of Evotec’s capital. Market observers suggest the firm might expand its position while prices remain low, which could help stabilise the stock. However, no clear signs of a recovery have emerged yet. Analysts warn that the €5.00 level is critical for Evotec’s shares. A drop below this threshold could trigger another wave of selling, pushing the price even lower. With operational losses mounting and technical indicators weak, the outlook stays uncertain.
Evotec’s stock has lost 40% from its 52-week high, leaving it vulnerable to further declines. Without new investment or improved financial performance, the downward trend may continue. The next few trading sessions will be closely watched for signs of stabilisation.
Read also:
- India's Agriculture Minister Reviews Sector Progress Amid Heavy Rains, Crop Areas Up
- Cyprus, Kuwait Strengthen Strategic Partnership with Upcoming Ministerial Meeting
- Inspired & Paddy Power Extend Virtual Sports Partnership for UK & Ireland Retail
- South West & South East England: Check & Object to Lorry Operator Licensing Now
